Explore approved therapies, indication limits, topical options, and research compounds without turning uncertainty into a protocol.
Education and decision support. This release does not generate doses, injection instructions, cycles, diagnoses, prescriptions, or vendor pathways.
Choose one. You can switch or skip at any time.
These rankings are deterministic and explain their fit and limits.
A well-characterized GLP-1 therapy with product-specific FDA indications and substantial human evidence.
Visible for broad education until a goal is selected.
FDA approved for defined indications.
An approved GHRF analog whose labeled indication is substantially narrower than common wellness marketing suggests.
Visible for broad education until a goal is selected.
FDA approved for a narrow indication.
A dual GIP/GLP-1 therapy with product-specific FDA indications and substantial human evidence.
Visible for broad education until a goal is selected.
FDA approved for defined indications.